Ignite Creation Date:
2024-05-06 @ 6:08 PM
Last Modification Date:
2024-10-26 @ 2:43 PM
Study NCT ID:
NCT05569655
Status:
UNKNOWN
Last Update Posted:
2022-10-06
First Post:
2022-10-01
Brief Title:
Efficacy and Safety Evaluation of Tolvaptan in the Treatment of Patients With RHF Caused by PAH
Sponsor:
Chinese Pulmonary Vascular Disease Research Group
Organization:
Chinese Pulmonary Vascular Disease Research Group
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-06
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-10-01
First Submit QC Date:
October 4 2022
Study First Post Date:
2022-10-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-04
Last Update Post Date:
2022-10-06
Last Update Post Date Type:
ACTUAL